Fri, March 22, 2024
Thu, March 21, 2024
Wed, March 20, 2024
Tue, March 19, 2024
Mon, March 18, 2024

Anupam Rama Maintained (BBIO) at Buy with Increased Target to $45 on, Mar 20th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-45-on-mar-20th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Anupam Rama of JP Morgan, Maintained "BridgeBio Pharma, Inc." (BBIO) at Buy with Increased Target from $35 to $45 on, Mar 20th, 2024.

Anupam has made no other calls on BBIO in the last 4 months.



There are 5 other peers that have a rating on BBIO. Out of the 5 peers that are also analyzing BBIO, 1 agrees with Anupam's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Kostas Biliouris of "BMO Capital" Initiated at Hold and Held Target at $37 on, Wednesday, January 31st, 2024


These are the ratings of the 4 analyists that currently disagree with Anupam


  • Josh Schimmer of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $70 on, Tuesday, March 19th, 2024
  • Salim Syed of "Mizuho" Maintained at Strong Buy with Decreased Target to $53 on, Tuesday, March 5th, 2024
  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $47 on, Monday, March 4th, 2024
  • David Lebowitz of "Citigroup" Maintained at Strong Buy with Increased Target to $46 on, Friday, February 23rd, 2024

Publication Contributing Sources